Opens in a new tab

Dr. Zhou Canquan

Chinese name: 周灿权
Professor, Chief Physician, Doctoral Supervisor . Reproductive Medicine
Professor Zhou Canquan is academic leader of the Reproductive Medicine Center at the First Affiliated Hospital of Sun Yat-sen University and a professor of obstetrics and gynaecology. A pioneer of assisted reproductive technology in China, he helped build one of the country's first in-vitro fertilisation programmes and advanced preimplantation genetic diagnosis and fertility treatment.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

39 years
Assisted reproductive medicine practice
4,000+ per year
IVF-ET cycles performed at the centre
about 45%
Clinical pregnancy rate of IVF-ET

  • The Physician

About Dr. Zhou Canquan

Professor Zhou Canquan is academic leader of the Reproductive Medicine Center at the First Affiliated Hospital of Sun Yat-sen University and a professor of obstetrics and gynaecology. He began working in assisted reproductive technology in 1987 and, as a core member of the team, helped establish the hospital's reproductive medicine centre and its in-vitro fertilisation programme in 1989. He has devoted his career to infertility treatment and reproductive genetics, advancing preimplantation genetic diagnosis for thalassaemia and other inherited diseases, and has trained many specialists who now lead reproductive medicine services across China.
1、Academic leader of the Reproductive Medicine Center at the First Affiliated Hospital of Sun Yat-sen University
2、Former Vice President of the First Affiliated Hospital of Sun Yat-sen University
3、Professor and doctoral supervisor of obstetrics and gynaecology
4、Core member who helped establish the hospital’s reproductive medicine centre and IVF programme
5、Pioneer of preimplantation genetic diagnosis for thalassaemia in China
6、Trainer of many reproductive medicine specialists nationwide

Dr. Zhou Canquan ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

In-vitro fertilisation

He provides in-vitro fertilisation and other assisted reproductive treatments for couples with infertility, individualising ovarian stimulation, embryo culture and transfer to maximise the chance of a healthy pregnancy while minimising complications for women and their babies and families in routine clinical practice.

Preimplantation genetic diagnosis

He pioneered preimplantation genetic diagnosis in China, allowing embryos to be screened for thalassaemia and other inherited diseases before transfer, so that couples at risk of passing on serious genetic disorders can have an unaffected child of their own in clinical practice.

Complex infertility and menstrual disorders

He diagnoses and treats complex infertility, menstrual disorders and reproductive endocrine disease, integrating hormonal assessment, ultrasound and laboratory testing to identify the cause and design individualised treatment plans for women with difficult fertility problems and their partners in routine care.

More：male infertility——assessment; recurrent miscarriage——management; fertility preservation——counselling; ovarian reserve——evaluation; reproductive genetics——testing

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Preimplantation genetic diagnosis for alpha- and beta-thalassemia
This clinical programme applied fluorescent gap PCR and multiplex nested PCR to screen embryos before transfer for couples who are both thalassemia carriers. Among eight couples treated, three pregnancies were achieved and three healthy babies were born, confirming the accuracy of preimplantation genetic diagnosis for thalassemia carriers.
2. Noninvasive medium-based screening for alpha-thalassemia-SEA embryos
This study established a noninvasive method that detects the Southeast Asian deletion causing alpha-thalassemia from culture medium, avoiding blastomere biopsy. Testing 413 embryos from 38 carrier couples, the approach identified affected and unaffected embryos accurately, offering thalassemia carrier couples undergoing in vitro fertilisation a safer way to select healthy embryos.
3. Karyomapping-based preimplantation genetic testing with HLA matching
This systematic summary evaluated karyomapping for beta-thalassemia families who also need a human leukocyte antigen-matched donor sibling. Combining mutation detection with HLA matching in a single embryo test shortens the diagnostic workflow and improves reliability, helping carrier couples conceive a healthy, immunologically compatible child through in vitro fertilisation.
4. Pregnancy outcomes in polycystic ovary syndrome after frozen blastocyst transfer
This propensity score-matched study compared pregnancy outcomes in women with polycystic ovary syndrome who conceived after single thawed blastocyst transfer with those of women without the condition. The findings support individualised frozen embryo transfer protocols and careful metabolic and endometrial preparation for infertility patients with polycystic ovary syndrome.
5. Preventing ovarian hyperstimulation syndrome during IVF stimulation
This systematic review and network meta-analysis compared pharmacological strategies used to prevent ovarian hyperstimulation syndrome in women undergoing controlled ovarian stimulation. It provides clinicians with comparative evidence for choosing preventive treatment, an important safety measure for patients at risk of ovarian hyperstimulation syndrome during in vitro fertilisation treatment.
6. Twin pregnancy outcomes after in vitro fertilisation
This large retrospective study examined dichorionic diamniotic twin pregnancies after in vitro fertilisation and the effect of spontaneous fetal reduction on maternal and neonatal outcomes. The results help clinicians counsel infertility patients about multifetal pregnancy risk and guide monitoring and management during twin pregnancy following assisted reproduction.
  • Affiliated Hospital

Where Dr. Zhou Canquan practices

Guangzhou

The First Affiliated Hospital, Sun Yat-sen University

Chinese name: 中山大学附属第一医院
Founded in 1910, the First Affiliated Hospital of Sun Yat-sen University, a national comprehensive medical university hospital, holds 36 national clinical key specialties, serves 15,000 daily outpatients, achieved A++ national performance rating and pioneered the world's first ischemia-free organ transplant.
Since 1910
116 years of care
36
National key specialties
15,000+
Daily outpatient visits
327
National key specialties
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Zhou Canquan?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Zhou Canquan.